Moleculin Expands Global IP Portfolio with New Australian Patent for Annamycin GlobeNewswire October 29, 2025 HOUSTON, Oct. 29, 2025 (GLOBE NEWSWIRE) — Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat cancers and viral infections, today announced that the Australian Patent Office […]

AI & Technology Virtual Investor Conference: Presentations Now Available for Online Viewing Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com GlobeNewswire October 29, 2025 NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) — Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the AI & Technology Virtual Investor Conference,

First Pacific to Present at the dbVIC – Deutsche Bank ADR Virtual Investor Conference November 4th Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com GlobeNewswire October 29, 2025 HONG KONG, Oct. 29, 2025 (GLOBE NEWSWIRE) — First Pacific Company Limited (Hong Kong: 00142, ADR: FPAFY), based

Belite Bio to Present at the dbVIC – Deutsche Bank ADR Virtual Investor Conference November 4th Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com GlobeNewswire October 29, 2025 SAN DIEGO, Oct. 29, 2025 (GLOBE NEWSWIRE) — Belite Bio Inc (NASDAQ: BLTE) (“Belite” or the “Company”), a

GeneVentiv Therapeutics, Inc., a privately held biotechnology company developing one-time gene therapies for rare and inherited diseases, today announced that it held a successful INTERACT meeting with the U.S. Food and Drug Administration (FDA) for the Company's lead program, GENV-HEM, a novel gene therapy for Hemophilia A with or without inhibitors (antibodies to Factor VIII).

Mimeo Photos, a leader in premium photo products, today announced the beta release of Arlo: AI Print Studio, a groundbreaking app that leverages artificial intelligence to enhance the joy of creating photo books. https://mma.prnewswire.com/media/2807461/Arlo_Desktop_Mimeo_Photos.jpg Available now on the web, in the Mac App Store, and in the iOS App Store, Arlo transforms the traditional photo

At the “Innovate & Connect: Global Business Gala 2025” hosted by Made-in-China.com, the platform officially unveiled SourcingAI 2.0, marking a new milestone in applying artificial intelligence to empower global sourcing through end-to-end buyer-seller collaboration and full-chain intelligence. The event brought together top global buyers and selected suppliers, alongside representatives from the Polish-Chinese Chamber of Commerce,

Amid new tariffs and policy shifts, SHARx stays focused on tackling rising U.S. drug costs with a fully transparent, patient-first pricing model that eliminates hidden fees while keeping medications accessible. Employers, brokers, and policymakers now have a clear, ethical alternative to the stronghold traditional PBMs have on plan fiduciaries. The prescription drug affordability crisis in

Halloween may bring its fair share of ghosts and goblins, but for many Northeast Florida businesses, the real fright comes from hackers lurking behind outdated systems and weak passwords. DefinIT is helping small and mid-sized companies keep their data from becoming the next cybersecurity horror story. “Cyber threats don't wait for midnight to strike –

GetPer4mance.com, the official home of Per4mance Development LLC, has shifted into high gear with the latest upgrade to its patented DIRS-R Differential Brace and all-in-one Ultimate Package Kit. Engineered for serious racers driving 2015-2023 Dodge Charger, Challenger, Demon 170, and Chrysler 300 V8 models, these enhancements build on years of proven results in the Mopar